ArticleFrontiers in oncology2023

A phase II randomized clinical trial to assess toxicity and quality of life of breast cancer patients with hypofractionated versus conventional fractionation radiotherapy with regional nodal irradiation in the context of COVID-19 crisis.

Gabriel Oliveira Bernardes Gil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.